Literature DB >> 19095765

Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury.

Tong Shi1, Vaishali R Moulton, Peter H Lapchak, Guo-Min Deng, Jurandir J Dalle Lucca, George C Tsokos.   

Abstract

Ischemia-reperfusion (IR) injury represents a major clinical challenge, which contributes to morbidity and mortality during surgery. The critical role of natural immunoglobulin M (IgM) and complement in tissue injury has been demonstrated. However, cellular mechanisms that result in the deposition of natural IgM and the activation of complement are still unclear. In this report, using a murine intestinal IR injury model, we demonstrated that the beta-actin protein in the small intestine was cleaved and actin filaments in the columnar epithelial cells were aggregated after a transient disruption during 30 min of ischemia. Ischemia also led to deposition of natural IgM and complement 3 (C3). A low dose of cytochalasin D, a depolymerization reagent of the actin cytoskeleton, attenuated this deposition and also attenuated intestinal tissue injury in a dose-dependent manner. In contrast, high doses of cytochalasin D failed to worsen the injury. These data indicate that ischemia-mediated aggregation of the actin cytoskeleton, rather than its disruption, results directly in the deposition of natural IgM and C3. We conclude that ischemia-mediated aggregation of the actin cytoskeleton leads to the deposition of natural IgM and the activation of complement, as well as tissue injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095765     DOI: 10.1152/ajpgi.90607.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.

Authors:  Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

Review 2.  Recent advances in small bowel diseases: Part I.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 3.  The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunity.

Authors:  Walter G Land
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

4.  Solid-phase immunoglobulins IgG and IgM activate macrophages with solid-phase IgM acting via a novel scavenger receptor a pathway.

Authors:  Joseph J Boyle; Ivy Christou; M Bilal Iqbal; Aivi T Nguyen; Viola W Y Leung; Paul C Evans; Yu Liu; Michael Johns; Paul Kirkham; Dorian O Haskard
Journal:  Am J Pathol       Date:  2012-05-30       Impact factor: 4.307

5.  Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury.

Authors:  Haekyung Lee; Danielle J Green; Lawrence Lai; Yunfang Joan Hou; Jens C Jensenius; David Liu; Cheolho Cheong; Chae Gyu Park; Ming Zhang
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

6.  Antibiotics increase gut metabolism and antioxidant proteins and decrease acute phase response and necrotizing enterocolitis in preterm neonates.

Authors:  Pingping Jiang; Michael Ladegaard Jensen; Malene Skovsted Cilieborg; Thomas Thymann; Jennifer Man-Fan Wan; Wai-Hung Sit; George L Tipoe; Per Torp Sangild
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 7.  Danger signals - damaged-self recognition across the tree of life.

Authors:  Martin Heil; Walter G Land
Journal:  Front Plant Sci       Date:  2014-10-31       Impact factor: 5.753

Review 8.  The innate immune system and transplantation.

Authors:  Conrad A Farrar; Jerzy W Kupiec-Weglinski; Steven H Sacks
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

9.  Which pathways trigger the role of complement in ischaemia/reperfusion injury?

Authors:  Conrad A Farrar; Elham Asgari; Wilhelm J Schwaeble; Steven H Sacks
Journal:  Front Immunol       Date:  2012-11-19       Impact factor: 7.561

10.  The Composite of 3, 4-Dihydroxyl-Phenyl Lactic Acid and Notoginsenoside R1 Attenuates Myocardial Ischemia and Reperfusion Injury Through Regulating Mitochondrial Respiratory Chain.

Authors:  Li Yan; Chun-Shui Pan; Yu-Ying Liu; Yuan-Chen Cui; Bai-He Hu; Xin Chang; Xiao-Hong Wei; Ping Huang; Jian Liu; Jing-Yu Fan; Quan Li; Kai Sun; Lu-Lu Yan; Ke He; Jing-Yan Han
Journal:  Front Physiol       Date:  2021-07-12       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.